Arcus Biosciences Inc (RCUS) Insider Trading
- $564,820,580.75
- $9,182,729.97
- Sept. 5, 2025
- Jennifer Jarrett
| Trader Name | Date | Title | Amount | Price | Type | Total Value | 
|---|---|---|---|---|---|---|
| Sept. 5, 2025 | CAO | 1,579 | $11.88 | Sell | $18,758.52 | |
| Feb. 27, 2025 | Director | 20,000 | $10.06 | Buy | $201,200.00 | |
| Feb. 27, 2025 | CEO | 19,800 | $10.18 | Buy | $201,564.00 | |
| Dec. 31, 2024 | CFO | 3,594 | $15.00 | Sell | $53,910.00 | |
| Dec. 2, 2024 | CAO | 201 | $15.32 | Sell | $3,079.32 | |
| March 27, 2024 | COO | 11,551 | $17.55 | Sell | $202,720.05 | |
| March 18, 2024 | COO | 13,449 | $17.92 | Sell | $241,006.08 | |
| Feb. 26, 2024 | President | 3,900 | $20.06 | Sell | $78,234.00 | |
| Feb. 26, 2024 | COO | 24,555 | $20.07 | Sell | $492,818.85 | |
| Jan. 29, 2024 | Major Shareholder | 15,238,095 | $21.00 | Buy | $319,999,995.00 | |
| Jan. 2, 2024 | CFO | 2,004 | $20.00 | Sell | $40,080.00 | |
| Jan. 2, 2024 | President | 6,975 | $20.09 | Sell | $140,127.75 | |
| Dec. 22, 2023 | COO | 21,521 | $17.76 | Sell | $382,212.96 | |
| Sept. 22, 2023 | COO | 21,369 | $19.99 | Sell | $427,166.31 | |
| July 28, 2023 | COO | 45,000 | $20.25 | Sell | $911,250.00 | |
| July 3, 2023 | CAO | 1,018 | $20.41 | Sell | $20,777.38 | |
| June 28, 2023 | Major Shareholder | 1,010,000 | $19.26 | Buy | $19,452,600.00 | |
| June 22, 2023 | COO | 12,437 | $19.12 | Sell | $237,795.44 | |
| June 16, 2023 | COO | 12,563 | $19.35 | Sell | $243,094.05 | |
| March 16, 2023 | COO | 8,729 | $16.81 | Sell | $146,734.49 | |
| Jan. 26, 2023 | COO | 300 | $23.56 | Sell | $7,068.00 | |
| Dec. 16, 2022 | CEO | 13,043 | $30.75 | Sell | $401,072.25 | |
| Dec. 16, 2022 | General Counsel | 2,523 | $30.75 | Sell | $77,582.25 | |
| Dec. 16, 2022 | COO | 16,482 | $30.75 | Sell | $506,821.50 | |
| Dec. 16, 2022 | President | 4,436 | $30.75 | Sell | $136,407.00 | |
| Dec. 16, 2022 | CFO | 2,453 | $30.75 | Sell | $75,429.75 | |
| Sept. 16, 2022 | COO | 12,677 | $26.28 | Sell | $333,151.56 | |
| June 16, 2022 | President | 2,333 | $20.72 | Sell | $48,339.76 | |
| June 16, 2022 | CEO | 4,241 | $20.72 | Sell | $87,873.52 | |
| June 16, 2022 | General Counsel | 1,400 | $20.72 | Sell | $29,008.00 | |
| June 16, 2022 | COO | 6,081 | $20.72 | Sell | $125,998.32 | |
| March 16, 2022 | COO | 9,617 | $31.62 | Sell | $304,089.54 | |
| Dec. 20, 2021 | COO | 34,822 | $41.48 | Sell | $1,444,416.56 | |
| Dec. 16, 2021 | CFO | 485 | $39.83 | Sell | $19,317.55 | |
| Dec. 16, 2021 | COO | 5,560 | $39.82 | Sell | $221,399.20 | |
| Dec. 16, 2021 | General Counsel | 487 | $39.82 | Sell | $19,392.34 | |
| Dec. 16, 2021 | President | 865 | $39.82 | Sell | $34,444.30 | |
| Dec. 16, 2021 | CEO | 2,299 | $39.82 | Sell | $91,546.18 | |
| Sept. 20, 2021 | COO | 30,634 | $35.18 | Sell | $1,077,704.12 | |
| June 16, 2021 | General Counsel | 1,309 | $24.16 | Sell | $31,625.44 | |
| June 4, 2021 | COO | 1,044 | $24.91 | Sell | $26,006.04 | |
| April 23, 2021 | Director | 4,133 | $31.37 | Buy | $129,652.21 | |
| March 31, 2021 | Director | 20,000 | $28.35 | Buy | $567,000.00 | |
| March 16, 2021 | COO | 8,661 | $35.03 | Sell | $303,394.83 | |
| March 16, 2021 | Insider | 2,127 | $35.03 | Sell | $74,508.81 | |
| Jan. 31, 2021 | Major Shareholder | 5,650,000 | $39.00 | Buy | $220,350,000.00 | |
| Dec. 16, 2020 | Insider | 2,117 | $31.35 | Sell | $66,367.95 | |
| Sept. 9, 2020 | CFO | 5,000 | $21.57 | Buy | $107,850.00 | |
| July 31, 2020 | Insider | 200 | $19.72 | Buy | $3,944.00 | |
| June 28, 2019 | President | 15,000 | $7.59 | Buy | $113,850.00 | 
- Insiders are both buying and selling Arcus Biosciences Inc stock. 
- The insider traders at Arcus Biosciences Inc are: Jennifer Jarrett, Terry J Rosen, Juan C Jaen, Robert C Goeltz II, Kathryn E Falberg, Alexander Azoy, Carolyn C Tang, William Grossman, Yasunori Kaneko, Gilead Sciences, Inc., Gilead Sciences Inc, and Carolyn C. Tang 
- The most active insider trader at Arcus Biosciences Inc is Jennifer Jarrett with 19 trades. 
- Jennifer Jarrett has sold the most Arcus Biosciences Inc stock with a total value of $7,837,567.95. 
- Gilead Sciences, Inc. has bought the most Arcus Biosciences Inc stock with a total value of $659,452,590.00. 
- The most recent insider trade for Arcus Biosciences Inc was on Sept. 5, 2025. 
- The single biggest insider buy for Arcus Biosciences Inc was from Gilead Sciences, Inc. with a total value of $319,999,995.00 on Jan. 29, 2024. 
- The single biggest insider sell for Arcus Biosciences Inc was from Jennifer Jarrett with a total value of $1,444,416.56 on Dec. 20, 2021. 
